Study of the Efficacy and Safety of Ferrlecit in the Maintenance Dosing in Hemodialysis Patients.
The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2008 by Watson Pharmaceuticals.
Recruitment status was Active, not recruiting
Recruitment status was Active, not recruiting
Sponsor:
Watson Pharmaceuticals
Information provided by:
Watson Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00223938
First received: September 13, 2005
Last updated: February 18, 2008
Last verified: February 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | September 2009 |
| Estimated Primary Completion Date: | September 2009 (Final data collection date for primary outcome measure) |